^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
FoundationOne®PGx

Type:
Research Use Only
Evidence

News

16d
Foundation Medicine to Launch FoundationOne®PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics (Foundation Medicine Press Release)
''Foundation Medicine, Inc...today announced plans to launch FoundationOne®PGx, a pharmacogenetic (PGx) offering to identify genetic differences that influence how medicines are metabolized and processed by the body. FoundationOne PGx will be offered in the United States through a partnership with Fulgent Genetics, Inc. (NASDAQ: FLGT) and will be available to order through the Foundation Medicine portal.''
Clinical
|
FoundationOne®PGx